All In Biotech

Free tool

FAERS Monitor: Cabometyx

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208692 or its brand name (Cabometyx, Cabozantinib S-Malate). Reports on generic versions are filed under their own applications.

Reports

45,867

Serious

20,559

45% of reports

Hospitalization

8,827

Death reported

5,123

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea8,923
  • fatigue7,330
  • off label use6,092
  • nausea4,724
  • decreased appetite4,414
  • malignant neoplasm progression3,284
  • blood pressure increased3,107
  • palmar-plantar erythrodysaesthesia syndrome3,042
  • weight decreased2,872
  • death2,797
  • stomatitis2,731
  • constipation2,284
  • vomiting2,093
  • asthenia2,006
  • taste disorder1,989

Reports by year received

View as table
YearReports
20111
20123
201316
2014107
201587
2016159
20171,452
20183,369
20193,853
20202,940
20214,546
20225,885
20236,053
20246,461
20256,037
20264,898

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,008,292 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
palmar-plantar erythrodysaesthesia syndromeSignal3,04268.766.2176,512
taste disorderSignal1,98949.747.585,713
stomatitisSignal2,73121.620.851,300
malignant neoplasm progressionSignal3,28415.214.742,230
blood pressure increasedSignal3,1079.59.223,285
decreased appetiteSignal4,4148.98.630,540
diarrhoeaSignal8,9236.46.341,479
constipationSignal2,2844.84.76,960
weight decreasedSignal2,8724.84.68,542
fatigueSignal7,3304.34.319,441
off label useSignal6,0923.23.19,578
nauseaSignal4,7242.72.75,421
astheniaSignal2,0062.52.41,749
vomitingSignal2,0932.02.01,139
death2,7971.51.4468

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.